Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 1,778.00
-2.00 (-0.11%)
At close: Aug 20, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 138.4 billion as of August 20, 2026. Its market cap has decreased by -51.50% in one year.
Market Cap
138.40B
Enterprise Value
222.83B
Revenue
18.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,778.00
ChartMarket Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 138.40B, a decrease of -77.43%. That is a compound annual growth rate of -23.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 138.40B | -41.35% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 221.23B |
| Kanaph Therapeutics | 194.82B |
| NIBEC | 181.20B |
| Bio Solution | 171.86B |
| Y-Biologics | 144.29B |
| Ensol Biosciences | 143.45B |
| ISU Abxis | 134.35B |
| TiumBio | 130.07B |